Release Date
Geography
Language of Resource
Full Text Available
Open Access / OK to Reproduce
Peer Reviewed
Objective
We examined prevalence and sociodemographic correlates of past year presumed xylazine effects and association with overdose and wound-related outcomes.
Findings/Key points
Almost two-thirds (61.5%) reported experiencing xylazine effects. There were no differences by socio-demographics, but xylazine effects were more commonly reported among those who reported injecting alone and daily fentanyl use. Those reporting xylazine exposure was three times as likely to report overdose and twice as likely to have used naloxone. They also more commonly reported knowing someone who died of an overdose and to report an abscess requiring medical attention. These associations were higher among respondents who specifically named xylazine and those who used fentanyl more frequently, but fentanyl frequency did not fully explain the heightened associations with xylazine effects.
Design/methods
We conducted a rapid behavioral survey among people who inject drugs (n = 96) in Baltimore November–December 2022